Related Experiment Video
Updated: Aug 14, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Progressive changes in diabetics and their management
1Vitreoretinal Surgical Unit, Moorfields Eye Hospital, City Road, London, UK. Bili.Aylward@moorfields.nhs.uk
Abstract:
The prevalence of diabetic retinopathy is increasing worldwide due to an increasing number, and prolonged survival, of diabetic patients. Many effective treatments for different types and stages of retinopathy exist. However, there is patchy delivery of care, inconsistent screening, and unresolved questions about several management questions. This article discusses the current state of knowledge about therapeutics in diabetic retinopathy, and highlights areas where further studies and evidence base is required.
Insights
Diabetic retinopathy (DR) is rising globally. While treatments exist, inconsistent screening and care gaps necessitate further research for better management of this diabetes complication.
Area of Science:
- Ophthalmology
- Endocrinology
- Public Health
Background:
- Rising global prevalence of diabetic retinopathy linked to increased diabetes incidence and patient longevity.
- Existing treatments for diabetic retinopathy are effective across various stages.
- Significant challenges persist, including disparities in care delivery and screening inconsistencies.
Purpose of the Study:
- To review current therapeutic knowledge for diabetic retinopathy.
- To identify gaps in evidence and areas requiring further research.
- To inform future clinical practice and research directions.
Main Methods:
- Literature review of current therapeutic strategies for diabetic retinopathy.
- Analysis of existing evidence on treatment efficacy and outcomes.
- Identification of unresolved management questions and research needs.
Main Results:
- A range of effective treatments are available for diabetic retinopathy.
- Current care delivery and screening practices are inconsistent.
- Several key questions regarding the management of diabetic retinopathy remain unanswered.
Conclusions:
- Despite available treatments, suboptimal care delivery and screening hinder effective diabetic retinopathy management.
- Further research is crucial to address evidence gaps and improve patient outcomes.
- Enhanced strategies are needed to optimize the treatment and long-term care of diabetic retinopathy.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetic Nephropathy
Diabetes: Symptoms, Diagnosis, and Complications
Complications of Diabetes Mellitus